Ruolan Xia

1.1k total citations · 3 hit papers
14 papers, 631 citations indexed

About

Ruolan Xia is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ruolan Xia has authored 14 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Ruolan Xia's work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Ruolan Xia is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Ruolan Xia collaborates with scholars based in China. Ruolan Xia's co-authors include Maosen Xu, Yuquan Wei, Xiawei Wei, Yang Wang, Tao Zhang, Xuelei Ma, Yuwen Zhou, Yu Zhang, Hong Qian and Xiuhe Zou and has published in prestigious journals such as Molecular Cancer, Frontiers in Oncology and International Immunopharmacology.

In The Last Decade

Ruolan Xia

14 papers receiving 623 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

2021 213 citations Maosen Xu, Yang Wang et al. Cell Proliferation profile →
Targeting the tumor stroma for cancer therapy

2022 175 citations Maosen Xu, Tao Zhang et al. Molecular Cancer profile →
Game-based learning in medical education

2023 78 citations Maosen Xu, Yong Luo et al. Frontiers in Public Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruolan Xia China	9	285	176	172	86	83	14	631
Maosen Xu China	4	219 0.8×	155 0.9×	167 1.0×	45 0.5×	41 0.5×	9	506
Juan P. Fusco Spain	8	487 1.7×	122 0.7×	417 2.4×	172 2.0×	38 0.5×	15	761
Shane E. Holloway United States	12	276 1.0×	340 1.9×	163 0.9×	70 0.8×	177 2.1×	14	921
Lisa M. Becker United States	12	198 0.7×	305 1.7×	142 0.8×	53 0.6×	45 0.5×	18	706
Lena Seifert Germany	15	548 1.9×	225 1.3×	545 3.2×	106 1.2×	71 0.9×	30	1000
Denise M. Woods United States	8	290 1.0×	330 1.9×	45 0.3×	231 2.7×	82 1.0×	15	686
Michael D. Curley United States	9	400 1.4×	307 1.7×	61 0.4×	39 0.5×	35 0.4×	19	636
Iben Spanggaard Denmark	15	239 0.8×	110 0.6×	69 0.4×	118 1.4×	85 1.0×	43	561
Xiaojing Yang China	14	167 0.6×	209 1.2×	61 0.4×	145 1.7×	78 0.9×	55	594
Qi Zhu China	20	328 1.2×	259 1.5×	105 0.6×	135 1.6×	228 2.7×	59	1.0k

Countries citing papers authored by Ruolan Xia

Since Specialization

Citations

This map shows the geographic impact of Ruolan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolan Xia more than expected).

Fields of papers citing papers by Ruolan Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruolan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolan Xia. The network helps show where Ruolan Xia may publish in the future.

Co-authorship network of co-authors of Ruolan Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Ruolan Xia. A scholar is included among the top collaborators of Ruolan Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruolan Xia. Ruolan Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Xu, Maosen, Li Xu, Tao Zhang, et al.. (2025). Dual MNK/VEGFR2 Inhibitor JDB153 Enhances Immunotherapeutic Efficiency and Chemosensitivity in Lung Cancer. MedComm. 6(5). e70155–e70155. 1 indexed citations

Xia, Ruolan, et al.. (2023). Immunotherapy or antiangiogenic therapy plus chemotherapy as first‐line treatment of patients with PD‐L1(‐) advanced non‐squamous non‐small cell lung cancer in a Chinese cohort. Cancer Medicine. 12(13). 14282–14292. 3 indexed citations

Xu, Maosen, Yong Luo, Yu Zhang, et al.. (2023). Game-based learning in medical education. Frontiers in Public Health. 11. 1113682–1113682. 78 indexed citations breakdown →

Zhou, Yuwen, Yan Wang, Ruolan Xia, Jiyan Liu, & Xuelei Ma. (2022). Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management. International Journal of Ophthalmology. 15(4). 646–656. 21 indexed citations

Xu, Maosen, Tao Zhang, Ruolan Xia, Yuquan Wei, & Xiawei Wei. (2022). Targeting the tumor stroma for cancer therapy. Molecular Cancer. 21(1). 208–208. 175 indexed citations breakdown →

Zhao, Yifan, Xiong Deng, Shiqiang Liu, et al.. (2022). Current field distribution calculation for water-blocking cushion layer of HV XLPE cable. IET conference proceedings.. 2021(15). 1320–1324. 2 indexed citations

Xia, Ruolan, Maosen Xu, Jing Yang, & Xuelei Ma. (2022). The role of Hedgehog and Notch signaling pathway in cancer. Molecular Biomedicine. 3(1). 38 indexed citations

Wang, Yuqing, Yuwen Zhou, Yueyun Chen, Ruolan Xia, & Jiyan Liu. (2022). Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-Database. Technology in Cancer Research & Treatment. 21. 2213848421–2213848421. 1 indexed citations

Xia, Ruolan, Yuan Cheng, Xuejiao Han, Yuquan Wei, & Xiawei Wei. (2021). Ikaros Proteins in Tumor: Current Perspectives and New Developments. Frontiers in Molecular Biosciences. 8. 788440–788440. 11 indexed citations

10.

Xia, Ruolan, et al.. (2021). Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments. Frontiers in Oncology. 11. 633916–633916. 42 indexed citations

11.

Zhou, Yuwen, Ruolan Xia, Yueyun Chen, Xuelei Ma, & Jiyan Liu. (2021). Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database. European Journal of Surgical Oncology. 47(8). 2108–2118. 8 indexed citations

12.

Cheng, Ke, Yuqing Wang, Yuwen Zhou, et al.. (2021). Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development. Clinical Medicine Insights Oncology. 15. 1353177221–1353177221. 8 indexed citations

13.

Xu, Maosen, Yang Wang, Ruolan Xia, Yuquan Wei, & Xiawei Wei. (2021). Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. Cell Proliferation. 54(10). 24–29. 213 indexed citations breakdown →

14.

Zhou, Yuwen, Ruolan Xia, Dan Pu, et al.. (2020). Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer. International Immunopharmacology. 91. 107296–107296. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact